Ranitidine Hydrochloride Oral Suspension Kit
Product Images NDC 70332-109

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ranitidine Hydrochloride Oral Suspension Kit (NDC 70332-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by California Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oral Suspension Vehicle Label (Oral Suspension Vehicle Label)

Oral Suspension Vehicle Label (Oral Suspension Vehicle Label)
This is an oral suspension product from California Pharmaceuticals LLC with a pineapple/orange flavor. It does not contain sugar, dye, and paraben but mainly comprises purified water, glycerin, pineapple and orange flavor, potassium sorbate, xanthan gum, etc. The net contents of the product are 250mL (8.4 fl oz). However, the text does not provide any information about the purpose of the product.*
FDA Label Image

Ranitidine Hydrochloride Principle Display (Ranitidine Hydrochloride Principle Display)

Ranitidine Hydrochloride Principle Display (Ranitidine Hydrochloride  Principle Display)
This text provides information about a Ranitidine Hydrochloride Oral Suspension kit containing active and inactive materials to prepare a medication with specialized needs. The kit is repackaged and distributed by California Pharmaceuticals, LLC, and contains 25.0 mg/mL of Ranitidine Hydrochloride. The kit is to be used for prescription compounding only upon a physician's prescription by an appropriate licensed medical professional. The kit contains active ingredients such as ranitidine hydrochloride USP and inactive ingredients like purified water, glycerin, and potassium sorbate. Moreover, the description mentions that the Ranitidine Hydrochloride Oral Suspension should be stored at room temperature, and that the kit should not be used if the safety seal is broken.*
FDA Label Image

Ranitidine Hydrochloride Insert 1 (Ranitidine Hydrochloride Insert 1)

Ranitidine Hydrochloride Insert 1 (Ranitidine Hydrochloride Insert 1)
This is a description of a prescription compounding kit containing ranitidine hydrochloride 25.0 mg/mL (equivalent to 22.4 mg/mL ranitidine) in a pineapple/orange oral suspension. The kit includes 6.4 g of ranitidine hydrochloride, 250 mL of oral suspension vehicle, a press-in bottle adaptor, an oral dispenser, and instructions. The kit is manufactured according to US FDA current Good Manufacturing Practice and can only be used for prescription compounding by a licensed medical professional. The pharmacist must remove and inspect the kit contents, wear gloves and eye protection, and follow compounding instructions carefully.*
FDA Label Image

Ranitidine Hydrochloride Insert 2 (Ranitidine Hydrochloride Insert 2)

Ranitidine Hydrochloride Insert 2 (Ranitidine Hydrochloride Insert 2)
The text is a set of instructions for mixing a prescription-only oral suspension with ranitidine hydrochloride powder equivalent to 22.4mg/mL ranitidine, into a pineapple/orange flavored vehicle. The final suspension is stable for up to eight weeks and requires re-labeling before use. An oral dispenser is provided. Store the unused kit at room temperature, and the mixed suspension must be stored between 2-8 Celsius.*
FDA Label Image

Ranitidine Hydrochloride Label (Ranitidine Hydrochloride Label)

Ranitidine Hydrochloride Label (Ranitidine Hydrochloride Label)
This is a description of a medication called Ranitidine Hydrochloride. It also includes information about the packaging and repackaging company, California Pharmaceuticals, LLC. However, the text appears to have several errors and does not provide clear and coherent information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.